Invasive thymoma: treatment with postoperative radiation therapy

Area of Science:

• Thoracic Oncology
• Radiation Oncology
• Medical Oncology

Background:

• Thymoma and thymic carcinoma are rare tumors of the thymus.
• Treatment strategies often involve surgery, radiation, and chemotherapy.

Purpose of the Study:

• To evaluate the effectiveness of radiation therapy and chemotherapy in treating invasive thymoma and thymic carcinoma.
• To assess survival outcomes and local control rates based on tumor type, stage, and treatment modality.

Main Methods:

• Retrospective analysis of 43 patients treated between 1981-1995 with resection and irradiation.
• Tumor types included thymic carcinoma (n=10) and invasive thymoma (n=33).
• Masaoka staging (II, III, IV) and chemotherapy use in 17 patients were analyzed.

Main Results:

• Thymic carcinoma showed significantly shorter median survival (9.5 months) than invasive thymoma (50 months).
• Survival rates decreased with advanced Masaoka stage (Stage II: 90%, Stage III: 67%, Stage IV: 30%).
• Local control within the radiation field was 81% and within the thorax was 74%.

Conclusions:

• Radical resection followed by 45-50 Gy radiation achieves local control.
• The benefit of adjuvant radiation for completely resected stage II thymomas is uncertain.
• The role of chemotherapy in thymoma treatment requires further investigation.